+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 118 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5724534
Description Jump to:

Industry Outlook

The Intravitreal injectables market will be showcasing stable growth at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2022 to 2030. According to the statistics provided by World Health Organization (WHO) approximately 1.3 billion people throughout the globe are suffering with some form of blindness caused majorly due to macular degeneration, diabetic retinopathy, ocular vein occlusions, endophthalmitis and retinitis. Intravitreal injections are being preferred over other treatment options for treating disease associated visual impairment.

Rising prevalence of diabetes and increasing geriatric population drive macular degeneration market growth

As per the research citing of the Lancet journal the global prevalence rate of any age related macular degeneration is 8.69% with a higher prevalence rate in the Caucasian population followed by mongoloids. The primary factors that increase the risk factor for occurrence of macular degeneration are increasing geriatric population, smoking, obesity, genetic, diabetes etc. Diabetic retinopathy is a secondary disease manifestation occurring in elderly people having previous history of diabetes. Endophthalmitis is growing at faster rate owing to rise in air and water pollution and eye trauma.

Excellent biocompatibility and impressive pharmacodynamic properties drive the anti-VEGF drugs market

Anti-VEGF is dominating the drug class segment for Intravitreal injections market. Since its commercialization in 2006 drugs such as bevacizumab (Avastin), ranibizumab (Lucentis) etc. are considered as the first line drug therapy in patients suffering with neovascular age related macular degeneration and ocular vein occlusion. Its inherent features such as excellent biocompatibility and impressive pharmacodynamic properties has led to its increased popularity among ophthalmologist worldwide. Corticosteroids are used as an adjuvant drug therapy in alleviating inflammation caused due to eye infections. Antifungal drugs and antibiotics together are prescribed in eye infections such as endophthalmitis and retinitis.

Rising prevalence of eye disorders and affordable reimbursement scenario drive the Intravitreal injectables market growth

In the present situation North America is accountable for 37% market share in the regional segment for Intravitreal injectables market. As per the statistics provided by the Center for Disease Control and Prevention (CDC), approximately 3.3 million Americans aged 40 years and older are blind or suffering with low vision. Rising prevalence of eye disorders and affordable reimbursement scenario drive the market growth in North America. Europe represents 26% share on account of the presence of thriving healthcare infrastructure and domicile of key players such as Novartis AG, Allergan, Inc., Alimera Sciences, F.Hoffman-La Roche Ltd. etc. propel the market growth in Europe. Asia Pacific is holding 20% market share and is keen to capture the regional market in the near future on account of supportive regulatory environment provided by healthcare agencies and developing ophthalmic research centers providing optimum eye care.

Pharmaceutical giants competing to maintain stronghold in intravitreal injectables market are Allergan, Inc., Genetech, Inc., Alimera Sciences, Bristol-Myers Squibb Company, Eyetech, Inc., F.Hoffman-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals, Inc., ThromboGenics, Inc. and Valeant Pharmaceuticals International, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Intravitreal Injectables market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Intravitreal Injectables market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Indication

  • Macular Degeneration
  • Diabetic Retinopathy
  • Retinal Vein Occlusions
  • Endophthalmitis
  • Others

Drug Class

  • Anti-VEGF
  • Corticosteroids
  • Antibiotics
  • Antivirals
  • Antifungals

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Intravitreal Injectables market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Intravitreal Injectables market?
  • Which is the largest regional market for Intravitreal Injectables market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Intravitreal Injectables market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Intravitreal Injectables market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Intravitreal Injectables Market
2.2. Global Intravitreal Injectables Market, By Indication, 2021 (US$ Million)
2.3. Global Intravitreal Injectables Market, By Drug Class, 2021 (US$ Million)
2.4. Global Intravitreal Injectables Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021

3. Intravitreal Injectables Market: Competitive Analysis
3.1. Market Positioning of Key Intravitreal Injectables Market Vendors
3.2. Strategies Adopted by Intravitreal Injectables Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Intravitreal Injectables Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Intravitreal Injectables Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Macular Degeneration
5.3.2. Diabetic Retinopathy
5.3.3. Retinal Vein Occlusions
5.3.4. Endophthalmitis
5.3.5. Others

6. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Anti-VEGF
6.3.2. Corticosteroids
6.3.3. Antibiotics
6.3.4. Antivirals
6.3.5. Antifungals

7. North America Intravitreal Injectables Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
7.3. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
7.4.Intravitreal Injectables Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
7.4.1.1.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
7.4.1.2.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
7.4.1.3.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)

8. UK and European Union Intravitreal Injectables Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.3. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
8.4.Intravitreal Injectables Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.4.1.1.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.4.1.2.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.4.1.3.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.4.1.4.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.4.1.5.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
8.4.1.6.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)

9. Asia Pacific Intravitreal Injectables Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.3. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
9.4.Intravitreal Injectables Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.4.1.1.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.4.1.2.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.4.1.3.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.4.1.4.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.4.1.5.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
9.4.1.6.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)

10. Latin America Intravitreal Injectables Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
10.3. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
10.4.Intravitreal Injectables Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
10.4.1.1.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
10.4.1.2.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
10.4.1.3.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)

11. Middle East and Africa Intravitreal Injectables Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
11.3. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
11.4.Intravitreal Injectables Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
11.4.1.1.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
11.4.1.2.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Intravitreal Injectables Market: By Indication, 2020-2030, USD (Million)
11.4.1.3.1. Intravitreal Injectables Market: By Drug Class, 2020-2030, USD (Million)

12. Company Profile
12.1. Allergan, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Alimera Sciences
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bristol-Myers Squibb Company
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Eyetech, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. F. Hoffmann-La Roche Ltd
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Genentech, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Novartis AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Regeneron Pharmaceuticals, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. ThromboGenics, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Valeant Pharmaceuticals International, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives

List of Figures
Figure 1 Global Intravitreal Injectables Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Intravitreal Injectables Market: Quality Assurance
Figure 5 Global Intravitreal Injectables Market, By Indication, 2021
Figure 6 Global Intravitreal Injectables Market, By Drug Class, 2021
Figure 7 Global Intravitreal Injectables Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Intravitreal Injectables Market, 2021
Figure 9 Market Positioning of Key Intravitreal Injectables Market Players, 2021
Figure 10 Global Intravitreal Injectables Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Intravitreal Injectables Market, By Indication, 2021 Vs 2030, %
Figure 12 Global Intravitreal Injectables Market, By Drug Class, 2021 Vs 2030, %
Figure 13 U.S. Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 14 Canada Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 16 UK Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 17 Germany Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 18 Spain Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 19 Italy Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 20 France Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 22 China Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 23 Japan Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 24 India Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 25 Australia Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 26 South Korea Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 28 Brazil Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 29 Mexico Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 31 GCC Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 32 Africa Intravitreal Injectables Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Intravitreal Injectables Market (US$ Million), 2020 - 2030

List of Tables
Table 1 Global Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 2 Global Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 3 North America Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 4 North America Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 5 U.S. Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 6 U.S. Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 7 Canada Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 8 Canada Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 9 Rest of North America Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 10 Rest of North America Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 11 UK and European Union Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 12 UK and European Union Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 13 UK Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 14 UK Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 15 Germany Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 16 Germany Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 17 Spain Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 18 Spain Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 19 Italy Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 20 Italy Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 21 France Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 22 France Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 23 Rest of Europe Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 24 Rest of Europe Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 25 Asia Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 26 Asia Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 27 China Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 28 China Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 29 Japan Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 30 Japan Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 31 India Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 32 India Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 33 Australia Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 34 Australia Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 35 South Korea Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 36 South Korea Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 37 Latin America Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 38 Latin America Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 39 Brazil Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 40 Brazil Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 41 Mexico Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 42 Mexico Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 43 Rest of Latin America Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 44 Rest of Latin America Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 45 Middle East and Africa Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 46 Middle East and Africa Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 47 GCC Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 48 GCC Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 49 Africa Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 50 Africa Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Intravitreal Injectables Market By Indication, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Intravitreal Injectables Market By Drug Class, 2020-2030, USD (Million)

Companies Mentioned

  • Allergan Inc.
  • Genetech Inc.
  • Alimera Sciences
  • Bristol-Myers Squibb Company
  • Eyetech Inc.
  • F.Hoffman-La Roche Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • ThromboGenics Inc.
  • Valeant Pharmaceuticals International Inc.

Related Topics

Related Reports

Intravitreal (IVT) Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Intravitreal (IVT) Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 276 Pages
  • Global
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029 - Product Image

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029

  • Report
  • 387 Pages
  • Global
From
Injectable Cytotoxic Drugs Market: Market Size, Trends, Opportunities and Forecast By Drug Class, Application, Distribution Channel, Region, By Country: 2020-2030 - Product Image

Injectable Cytotoxic Drugs Market: Market Size, Trends, Opportunities and Forecast By Drug Class, Application, Distribution Channel, Region, By Country: 2020-2030

  • Report
  • 310 Pages
  • Global
From
Sterile Injectable Drugs Market by Molecule Type, Drug, Indication, Distribution - Global Forecast 2025-2030 - Product Image

Sterile Injectable Drugs Market by Molecule Type, Drug, Indication, Distribution - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Injectable Drugs Market by Molecule Type, Drug Class, Injection Routes, Application - Global Forecast 2025-2030 - Product Image

Injectable Drugs Market by Molecule Type, Drug Class, Injection Routes, Application - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.